Historical record - last NADAC publication: 5/17/2023

Product Information

TELMISARTAN 20 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.1974 per EA under NDC 59746043932. Its NADAC has been published 281 times since Jan 10, 2018.

The High Outlier badge above means this manufacturer's average price in the Telmisartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TELMISARTAN 20 MG TABLET

Telmisartan
$0.1974per EA
High Outlier

Strength

20 mg/1

NDC

59746043932

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

5/17/2023

Active Ingredients

TELMISARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA204164

On Market Since

8/22/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for TELMISARTAN 20 MG TABLET has been published 281 times since Jan 10, 2018, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1974 per EA
All-time high$0.6122 (Mar 11, 2020)
All-time low$0.1853 (Apr 19, 2023)
Median price$0.4050
Average price$0.3769
Largest weekly change+40.2% (Mar 20, 2019)
Weeks tracked281
Tracking sinceJan 10, 2018

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

-59.0%

All

-48.9%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 20 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.1974 per EA (NDC 59746043932), effective May 24, 2023.

How has the price of TELMISARTAN 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for TELMISARTAN 20 MG TABLET has declined 48.9%. It has been tracked across 281 weekly CMS publications since Jan 10, 2018.

What are the highest and lowest recorded NADAC prices for TELMISARTAN 20 MG TABLET?

Since Jan 10, 2018, the NADAC for TELMISARTAN 20 MG TABLET has ranged from a low of $0.1853 (Apr 19, 2023) to a high of $0.6122 (Mar 11, 2020), with a median of $0.4050 per EA.

Are there cheaper alternatives to TELMISARTAN 20 MG TABLET?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TELMISARTAN 20 MG TABLET, is $0.1070 per EA — about 46% below TELMISARTAN 20 MG TABLET.

Who manufactures TELMISARTAN 20 MG TABLET?

TELMISARTAN 20 MG TABLET (NDC 59746043932) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.